Exozymes EXOZ
NASDAQ EXOZ
$4.14 -0.14 (-3.27%)
As of: Nov 10, 2026 · 11:34 AM EST

Exozymes (EXOZ) EBITDA Margin (2024 - 2026)

Updated

Exozymes' EBITDA Margin came in at -1995.24% for Q4 2025, down 726.37 percentage points from -1268.87% a year earlier but up 2167.41 percentage points from the prior quarter.

Analysis

Exozymes (EXOZ) EBITDA Margin (2024 - 2026) Analysis & Trends

For FY2025, Exozymes' EBITDA Margin was -2606.32%, up 4762.49 percentage points from FY2024.

  • Going back by year, EBITDA Margin was -7368.81% in FY2024 (-5012.38 pp) and -2356.43% in FY2023.
  • The five-year range for quarterly EBITDA Margin is -4162.64% (Q3 2025) to -1268.87% (Q4 2024).
  • Business Quant data shows EXOZ's EBITDA Margin at -4162.64% (Q3 2025), -3251.81% (Q2 2025) and -2008.00% (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Linde 238.84 Bn 220.98 Bn 4.44 Bn 33.12%
2 Corning 98.69 Bn 90.37 Bn 1.81 Bn 26.86%
3 Sherwin Williams 85.12 Bn 84.13 Bn 3.28 Bn 20.34%
4 Air Products & Chemicals 69.02 Bn 64.21 Bn 1.04 Bn -54.15%
5 LyondellBasell Industries 38.36 Bn 26.43 Bn 1.50 Bn 16.94%
6 Nutrien 34.35 Bn 30.38 Bn - -
7 Ppg Industries 27.44 Bn 20.36 Bn 1.76 Bn 17.96%
8 Qnity Electronics 26.06 Bn 22.20 Bn 743.00 Mn 34.45%
9 Ati 25.56 Bn 23.51 Bn 380.20 Mn 22.25%
10 Exozymes 36.29 Mn 21.05 Mn - -157,007.17%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -157,007.17%
Mar 31, 2026 -16,949.69%
Dec 31, 2025 -1,995.24%
Sep 30, 2025 -4,162.64%
Jun 30, 2025 -3,251.81%
Mar 31, 2025 -2,008.00%
Dec 31, 2024 -1,268.87%
API Access

Exozymes EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EXOZ&period=max&api_key=YOUR_API_KEY